ISSN 2146-832X
 

Original Research 


Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing

Florian T Unger, Susanne Bentz, Jana Krüger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprüssel, Hartmut Juhl, Kerstin A David.

Cited by (7)

Abstract
Background: To meet the urgent need to predict individual drug responses of patients and thus support drug development, better preclinical models of solid tumors are inevitable. Here, a newly developed precision cut cancer tissue slice culture is presented and its use in drug testing was evaluated. Methods: Efficacy of therapeutic compounds from different classes, i.e. Staurosporine, IRESSATM, and Herceptin® was tested within the drug testing platform using fresh precision cut cancer slices from human colon, lung, or breast tumor tissues. The stability and significance of the model were evaluated on the level of gene expression, by antibody diffusion assays, and drug responses were detected by immunohistochemical staining, Meso Scale Discovery (Akt, pAkt) analysis, Western blotting (pAkt, pMAPK), viability (ATP) and apoptosis assays (Caspase-3/7). Results: We obtained sufficient numbers of tissue slices from cancer specimens to be able to perform a wide range of experiments for each individual tumor. In our culture system, cells remained viable and proliferated for at least 4 days within their tissue environment. Viability of tissue slices decreased significantly due to therapeutic treatment in a dose-dependent manner. Gene expression varied remarkably in primary cultivated cells and HT-29 cells in comparison to cultivated tumor slices, which closely represent freshly isolated tumor tissue. An Alexa Fluor 488-labelled antibody showed diffusion in deeper cell layers and the ability of the system to evaluate effects of antibody therapy. Sustained viability of the precision cut cancer tissue slices over 72h enabled to test different drugs. Staurosporine, IRESSATM, and Herceptin® showed a dose-dependent reduction of viability and downstream signaling pathways like Akt and MAPK kinase phosphorylation in EGFR- or Her-2-positive Caco-2 or BT-474 cells or tissue slices, respectively. No effect was seen in EGFR- or Her-2-negative cells and tissues. Conclusions: We showed that this preclinical model is applicable to examine the effects of various anti-cancer compounds like cytotoxic chemotherapeutic drugs as well as targeted therapeutics. It may therefore have significant impact on drug development and patient selection for initial clinical trials.

Key words: Precision cut cancer tissue slices, primary cells, drug testing, 3D culture, chemotherapeutics, IRESSATM, Herceptin®


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Florian T Unger
Articles by Susanne Bentz
Articles by Jana Krüger
Articles by Cordula Rosenbrock
Articles by Janina Schaller
Articles by Katja Pursche
Articles by Annika Sprüssel
Articles by Hartmut Juhl
Articles by Kerstin A David
on Google
on Google Scholar
Article Statistics
 Viewed: 1403
Downloaded: 467
Cited: 7

REFERENCES
1. Roskelley CD, Bissell MJ: The dominance of the microenvironment in breast and ovarian cancer. Seminars in cancer biology 2002, 12:97-104. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
2. Allen M, Louise Jones J: Jekyll and Hyde: the role of the microenvironment on the progression of cancer. The Journal of pathology 2011, 223:162-176. [DOI via Crossref]    [Pubmed]   
3. Huang M, Shen A, Ding J, Geng M: Molecularly targeted cancer therapy: some lessons from the past decade. Trends in pharmacological sciences 2014, 35:41-50. [DOI via Crossref]    [Pubmed]   
4. Hensing T, Chawla A, Batra R, Salgia R: A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. Advances in experimental medicine and biology 2014, 799:85-117. [DOI via Crossref]    [Pubmed]   
5. Tredan O, Galmarini CM, Patel K, Tannock IF: Drug resistance and the solid tumor microenvironment. Journal of the National Cancer Institute 2007, 99:1441-1454. [DOI via Crossref]    [Pubmed]   
6. 6.Patocs A, Zhang L, Xu Y, Weber F, Caldes T, Mutter GL, Platzer P, Eng C: Breast-cancer stromal cells with TP53 mutations and nodal metastases. The New England journal of medicine 2007, 357:2543- 2551. [DOI via Crossref]    [Pubmed]   
7. Orimo A, Weinberg RA: Stromal fibroblasts in cancer: a novel tumorpromoting cell type. Cell cycle 2006, 5:1597-1601. [DOI via Crossref]    [Pubmed]   
8. Kinzler KW, Vogelstein B: Landscaping the cancer terrain. Science 1998, 280:1036-1037. [DOI via Crossref]    [Pubmed]   
9. Bissell MJ, Radisky D: Putting tumours in context. Nature reviews Cancer 2001, 1:46-54. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
10.Morin PJ: Drug resistance and the microenvironment: nature and nurture. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2003, 6:169-172.
11.Albertson DG, Collins C, McCormick F, Gray JW: Chromosome aberrations in solid tumors. Nature genetics 2003, 34:369-376. [DOI via Crossref]    [Pubmed]   
12.Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM, Tattersall MH: On the receiving end--patient perception of the sideeffects of cancer chemotherapy. European journal of cancer & clinical oncology 1983, 19:203-208. [DOI via Crossref]   
13.Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D: Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002, 95:155-163. [DOI via Crossref]    [Pubmed]   
14.Chow LW, Yiu CC, Yip AY, Loo WT: The future perspectives of breast cancer therapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2006, 60:259-262.
15.Sonnenberg M, van der Kuip H, Haubeis S, Fritz P, Schroth W, Friedel G, Simon W, Murdter TE, Aulitzky WE: Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast. BMC cancer 2008, 8:364. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
16.Dattatreya S: Metastatic colorectal cancer-prolonging overall survival with targeted therapies. South Asian journal of cancer 2013, 2:179-185. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
17.Li C: A targeted approach to cancer imaging and therapy. Nature materials 2014, 13:110-115. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
18.Workman P, Clarke P: PI3 Kinase in Cancer: From Biology to Clinic. American Society of Clinical Oncology educational book / ASCO American Society of Clinical Oncology Meeting 2012, 32:e93-e98.
19.Sahu A, Prabhash K, Noronha V, Joshi A, Desai S: Crizotinib: A comprehensive review. South Asian journal of cancer 2013, 2:91-97. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
20.Rosen LS, Gordon MS, Robert F, Matei DE: Endoglin for targeted cancer treatment. Current oncology reports 2014, 16:365. [DOI via Crossref]    [Pubmed]   
21.Burris HA: Trastuzumab Emtansine (T-DM1): Hitching a Ride on a Therapeutic Antibody. American Society of Clinical Oncology educational book / ASCO American Society of Clinical Oncology Meeting 2012, 32:159-161.
22.Shin TH, Sung ES, Kim YJ, Kim KS, Kim SH, Kim SK, Lee YD, Kim YS: Enhancement of the tumor penetration of monoclonal antibody by fusion of a neuropilin-targeting peptide improves the anti-tumor efficacy. Molecular cancer therapeutics 2014. [DOI via Crossref]    [PMC Free Fulltext]   
23.Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nature reviews Drug discovery 2006, 5:993-996. [DOI via Crossref]    [Pubmed]   
24.Kumar A, Rajendran V, Sethumadhavan R, Purohit R: AKT kinase pathway: a leading target in cancer research. TheScientificWorldJournal 2013, 2013:756134.
25.Siegfried Z, Bonomi S, Ghigna C, Karni R: Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer. International journal of cell biology 2013, 2013:568931.
26.Cooper WA, Lam DC, O'Toole SA, Minna JD: Molecular biology of lung cancer. Journal of thoracic disease 2013, 5:S479-S490. [Pubmed]    [PMC Free Fulltext]   
27.den Hollander P, Savage MI, Brown PH: Targeted Therapy for Breast Cancer Prevention. Frontiers in oncology 2013, 3:250. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
28.Das T, Meunier L, Barbe L, Provencher D, Guenat O, Gervais T, MesMasson AM: Empirical chemosensitivity testing in a spheroid model of ovarian cancer using a microfluidics-based multiplex platform. Biomicrofluidics 2013, 7:11805. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
29.Panowksi S, Bhakta S, Raab H, Polakis P, Junutula JR: Site-specific antibody drug conjugates for cancer therapy. mAbs 2014, 6:34-45. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
30.Eichelbaum M, Ingelman-Sundberg M, Evans WE: Pharmacogenomics and individualized drug therapy. Annual review of medicine 2006, 57:119-137. [DOI via Crossref]    [Pubmed]   
31.Masramon L, Vendrell E, Tarafa G, Capella G, Miro R, Ribas M, Peinado MA: Genetic instability and divergence of clonal populations in colon cancer cells in vitro. Journal of cell science 2006, 119:1477-1482. [DOI via Crossref]    [Pubmed]   
32.Thiery JP, Sleeman JP: Complex networks orchestrate epithelialmesenchymal transitions. Nature reviews Molecular cell biology 2006, 7:131-142. [DOI via Crossref]    [Pubmed]   
33.Kloss D, Fischer M, Rothermel A, Simon JC, Robitzki AA: Drug testing on 3D in vitro tissues trapped on a microcavity chip. Lab on a chip 2008, 8:879-884. [DOI via Crossref]    [Pubmed]   
34.Lin RZ, Chang HY: Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnology journal 2008, 3:1172-1184. [DOI via Crossref]    [Pubmed]   
35.Prestwich GD: Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery. Accounts of chemical research 2008, 41:139-148. [DOI via Crossref]    [Pubmed]   
36.Michalski CW, Erkan M, Sauliunaite D, Giese T, Stratmann R, Sartori C, Giese NA, Friess H, Kleeff J: Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer. British journal of cancer 2008, 99:760-767. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
37.Kitada N, Takara K, Minegaki T, Itoh C, Tsujimoto M, Sakaeda T, Yokoyama T: Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines. Cancer chemotherapy and pharmacology 2008, 62:577-584. [DOI via Crossref]    [Pubmed]   
38.Sharma SV, Haber DA, Settleman J: Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nature reviews Cancer 2010, 10:241-253. [DOI via Crossref]    [Pubmed]   
39.Sandberg R, Ernberg I: Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proceedings of the National Academy of Sciences of the United States of America 2005, 102:2052-2057. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
40.Lee W, Lockhart AC, Kim RB, Rothenberg ML: Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development. The oncologist 2005, 10:104-111. [DOI via Crossref]    [Pubmed]   
41.Kleeff J, Michalski C, Friess H, Buchler MW: Pancreatic cancer: from bench to 5-year survival. Pancreas 2006, 33:111-118. [DOI via Crossref]    [Pubmed]   
42.42. Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA: Spheroidbased drug screen: considerations and practical approach. Nature protocols 2009, 4:309-324. [DOI via Crossref]    [Pubmed]   
43.Buck E, Eyzaguirre A, Barr S, Thompson S, Sennello R, Young D, Iwata KK, Gibson NW, Cagnoni P, Haley JD: Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Molecular cancer therapeutics 2007, 6:532-541. [DOI via Crossref]    [Pubmed]   
44.Schmeichel KL, Bissell MJ: Modeling tissue-specific signaling and organ function in three dimensions. Journal of cell science 2003, 116:2377-2388. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
45. van der Kuip H, Murdter TE, Sonnenberg M, McClellan M, Gutzeit S, Gerteis A, Simon W, Fritz P, Aulitzky WE: Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC cancer 2006, 6:86. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
46.Guyot C, Combe C, Clouzeau-Girard H, Moronvalle-Halley V, Desmouliere A: Specific activation of the different fibrogenic cells in rat cultured liver slices mimicking in vivo situations. Virchows Archiv : an international journal of pathology 2007, 450:503-512.
47.Vaira V, Fedele G, Pyne S, Fasoli E, Zadra G, Bailey D, Snyder E, Faversani A, Coggi G, Flavin R, et al: Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:8352-8356. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
48.Raymond E, Faivre S, Woynarowski JM, Chaney SG: Oxaliplatin: mechanism of action and antineoplastic activity. Seminars in oncology 1998, 25:4-12. [Pubmed]   
49.Longley DB, Harkin DP, Johnston PG: 5-fluorouracil: mechanisms of action and clinical strategies. Nature reviews Cancer 2003, 3:330-338. [DOI via Crossref]    [Pubmed]   
50.Yagi Y, Sotani T, Nagao T, Horio T, Yamamoto I, Gohda E: Induction by staurosporine of hepatocyte growth factor production in human skin fibroblasts independent of protein kinase inhibition. Biochemical pharmacology 2003, 66:1797-1808. [DOI via Crossref]   
51.Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/ neu-overexpressing cells. Nature cell biology 2001, 3:245-252. [DOI via Crossref]    [Pubmed]   
52.Mahipal A, Kothari N, Gupta S: Epidermal growth factor receptor inhibitors: coming of age. Cancer control : journal of the Moffitt Cancer Center 2014, 21:74-79.
53.Kumler I, Tuxen MK, Nielsen DL: A systematic review of dual targeting in HER2-positive breast cancer. Cancer treatment reviews 2014, 40:259-270. [DOI via Crossref]    [Pubmed]   
54.Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, et al: Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. The New England journal of medicine 2004, 351:337-345. [DOI via Crossref]    [Pubmed]   
55.Halama N, Michel S, Kloor M, Zoernig I, Benner A, Spille A, Pommerencke T, von Knebel DM, Folprecht G, Luber B, et al: Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. Cancer research 2011, 71:5670-5677. [DOI via Crossref]    [Pubmed]   
56.Kamiyama H, Rauenzahn S, Shim JS, Karikari CA, Feldmann G, Hua L, Kamiyama M, Schuler FW, Lin MT, Beaty RM, et al: Personalized chemotherapy profiling using cancer cell lines from selectable mice. Clinical cancer research : an official journal of the American Association for Cancer Research 2013, 19:1139-1146.
57.Fukuda J, Mizumoto H, Nakazawa K, Kajiwara T, Funatsu K: Hepatocyte organoid culture in elliptic hollow fibers to develop a hybrid artificial liver. The International journal of artificial organs 2004, 27:1091-1099. [Pubmed]   
58.Parrish AR, Sallam K, Nyman DW, Orozco J, Cress AE, Dalkin BL, Nagle RB, Gandolfi AJ: Culturing Precision Cut Cancer human prostate slices as an in vitro model of prostate pathobiology. Cell biology and toxicology 2002, 18:205-219. [DOI via Crossref]    [Pubmed]   
59. van Geer MA, Kuhlmann KF, Bakker CT, ten Kate FJ, Oude Elferink RP, Bosma PJ: Ex-vivo evaluation of gene therapy vectors in human pancreatic (cancer) tissue slices. World journal of gastroenterology : WJG 2009, 15:1359-1366. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
60.Kirby TO, Rivera A, Rein D, Wang M, Ulasov I, Breidenbach M, Kataram M, Contreras JL, Krumdieck C, Yamamoto M, et al: A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity. Clinical cancer research : an official journal of the American Association for Cancer Research 2004, 10:8697-8703.
61.Stoff-Khalili MA, Stoff A, Rivera AA, Banerjee NS, Everts M, Young S, Siegal GP, Richter DF, Wang M, Dall P, et al: Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system. Breast cancer research : BCR 2005, 7:R1141-1152. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
62.Gerlach MM, Merz F, Wichmann G, Kubick C, Wittekind C, Lordick F, Dietz A, Bechmann I: Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance. British journal of cancer 2014, 110:479-488. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
63.Holliday DL, Moss MA, Pollock S, Lane S, Shaaban AM, Millican-Slater R, Nash C, Hanby AM, Speirs V: The practicalities of using tissue slices s preclinical organotypic breast cancer models. Journal of clinical pathology 2013, 66:253-255. [DOI via Crossref]    [Pubmed]   

This Article Cited By the following articles

An αv-RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and Opportunities
Angew. Chem. Int. Ed. 2018; (): .

1
 
Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry
Cell Reports 2018; 22(7): 1875.

2
 
Ein Instrumentarium von αv-RGD-Integrin-Inhibitoren: Wirkstoffsuche, Herausforderungen und Möglichkeiten
Angew. Chem. 2018; (): .

3
 
Increased immune cell infiltration in patient-derived tumor explants treated with Traniplatin: an original Pt(iv) pro-drug based on Cisplatin and Tranilast
Chem. Commun. 2018; 54(60): 8324.

4
 
Continuous monitoring of drug effects on complex biological samples by segmented flow chip calorimetry
J Therm Anal Calorim 2017; 127(2): 1307.

5
 
Pancreatic Cancer: Current Status and Challenges
Curr Pharmacol Rep 2017; (): .

6
 
Preclinical models for interrogating drug action in human cancers using Stable Isotope Resolved Metabolomics (SIRM)
Metabolomics 2016; 12(7): .

7
 
How to Cite this Article
Pubmed Style

Florian T Unger, Susanne Bentz, Jana Kruger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprussel, Hartmut Juhl, Kerstin A David. Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing . J Mol Pathophysiol. 2015; 4(3): 108-121. doi:10.5455/jmp.20151023055556


Web Style

Florian T Unger, Susanne Bentz, Jana Kruger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprussel, Hartmut Juhl, Kerstin A David. Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing . http://www.jmolpat.com/?mno=193324 [Access: December 13, 2018]. doi:10.5455/jmp.20151023055556


AMA (American Medical Association) Style

Florian T Unger, Susanne Bentz, Jana Kruger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprussel, Hartmut Juhl, Kerstin A David. Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing . J Mol Pathophysiol. 2015; 4(3): 108-121. doi:10.5455/jmp.20151023055556



Vancouver/ICMJE Style

Florian T Unger, Susanne Bentz, Jana Kruger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprussel, Hartmut Juhl, Kerstin A David. Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing . J Mol Pathophysiol. (2015), [cited December 13, 2018]; 4(3): 108-121. doi:10.5455/jmp.20151023055556



Harvard Style

Florian T Unger, Susanne Bentz, Jana Kruger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprussel, Hartmut Juhl, Kerstin A David (2015) Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing . J Mol Pathophysiol, 4 (3), 108-121. doi:10.5455/jmp.20151023055556



Turabian Style

Florian T Unger, Susanne Bentz, Jana Kruger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprussel, Hartmut Juhl, Kerstin A David. 2015. Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing . Journal of Molecular Pathophysiology, 4 (3), 108-121. doi:10.5455/jmp.20151023055556



Chicago Style

Florian T Unger, Susanne Bentz, Jana Kruger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprussel, Hartmut Juhl, Kerstin A David. "Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing ." Journal of Molecular Pathophysiology 4 (2015), 108-121. doi:10.5455/jmp.20151023055556



MLA (The Modern Language Association) Style

Florian T Unger, Susanne Bentz, Jana Kruger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprussel, Hartmut Juhl, Kerstin A David. "Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing ." Journal of Molecular Pathophysiology 4.3 (2015), 108-121. Print. doi:10.5455/jmp.20151023055556



APA (American Psychological Association) Style

Florian T Unger, Susanne Bentz, Jana Kruger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprussel, Hartmut Juhl, Kerstin A David (2015) Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing . Journal of Molecular Pathophysiology, 4 (3), 108-121. doi:10.5455/jmp.20151023055556





Most Viewed Articles
  • Prevention and treatment of cyclophosphamide and ifosfamide-induced hemorrhagic cystitis
    Ertan Altaylı, Ercan Malkoc, Bilal Fırat Alp, Ahmet Korkmaz
    J Mol Pathophysiol. 2012; 1(1): 53-62
    » Abstract & References » doi: 10.5455/jmp.20120321060902

  • Therapeutic potential of metals in managing diabetes mellitus: a review
    Geeta Pandey, Gyan Chand Jain, Nidhi Mathur
    J Mol Pathophysiol. 2012; 1(1): 63-76
    » Abstract & References » doi: 10.5455/jmp.20120410105457

  • Modulation of glucose and lipid metabolism in adrenalectomised rats given glycyrrhizic acid
    Yan Qi Ng, Chanchal Chandramouli, So Ha Ton, Khalid Abdul Kadir, Fahreen Haque, Melissa Sharmini Tamotharan
    J Mol Pathophysiol. 2012; 1(1): 3-20
    » Abstract & References » doi: 10.5455/jmp.20120221113254

  • Oxidative stress in acne vulgaris: an important therapeutic target
    Ahmed Salih Sahib, Haidar Hamid Al-Anbari, Ahmed R. Abu Raghif
    J Mol Pathophysiol. 2013; 2(1): 27-31
    » Abstract & References » doi: 10.5455/jmp.20130127102901

  • Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated
    Nicholas P Booth, Wells Brockbank, Samuel Oh, Karl Kingsley
    J Mol Pathophysiol. 2012; 1(1): 29-36
    » Abstract & References » doi: 10.5455/jmp.20120609040915

  • Cytotoxic effects of conjugated linoleic acids on human hepatoma cancer cells (HepG2)
    Achenef Melaku, Arifah Abdul Kadir, Fauziah Othman, Goh Yong Meng, Awis Qurni Sazili
    J Mol Pathophysiol. 2012; 1(1): 43-48
    » Abstract & References » doi: 10.5455/jmp.20120127120302

  • Role of intracellular adhesion molecules-1 (ICAM-1) in the pathogenesis of toxoplasmic retinochoroiditis
    Nagwa Mostafa El-Sayed, Khadiga Ahmed Ismail
    J Mol Pathophysiol. 2012; 1(1): 37-42
    » Abstract & References » doi: 10.5455/jmp.20120307042400

  • Periodontitis as a risk factor for cardiovascular disease with its treatment modalities: a review
    Amit Bhardwaj, Shalu V. Bhardwaj
    J Mol Pathophysiol. 2012; 1(1): 77-83
    » Abstract & References » doi: 10.5455/jmp.20120206034643

  • A new hope in biomedical research area; Journal of Molecular Pathophysiology
    Ahmet Korkmaz, Turgut Topal
    J Mol Pathophysiol. 2012; 1(1): 1-2
    » Abstract & References » doi: 10.5455/jmp.20120604123051

  • Arterial stiffness and inflammation in patients on hemodialysis
    Vaia D. Raikou, Despina Kyriaki, John N. Boletis
    J Mol Pathophysiol. 2012; 1(1): 21-28
    » Abstract & References » doi: 10.5455/jmp.20120530044656

  • Most Downloaded
  • Prevention and treatment of cyclophosphamide and ifosfamide-induced hemorrhagic cystitis
    Ertan Altaylı, Ercan Malkoc, Bilal Fırat Alp, Ahmet Korkmaz
    J Mol Pathophysiol. 2012; 1(1): 53-62
    » Abstract & References » doi: 10.5455/jmp.20120321060902

  • Oxidative stress in acne vulgaris: an important therapeutic target
    Ahmed Salih Sahib, Haidar Hamid Al-Anbari, Ahmed R. Abu Raghif
    J Mol Pathophysiol. 2013; 2(1): 27-31
    » Abstract & References » doi: 10.5455/jmp.20130127102901

  • Therapeutic potential of metals in managing diabetes mellitus: a review
    Geeta Pandey, Gyan Chand Jain, Nidhi Mathur
    J Mol Pathophysiol. 2012; 1(1): 63-76
    » Abstract & References » doi: 10.5455/jmp.20120410105457

  • A new hope in biomedical research area; Journal of Molecular Pathophysiology
    Ahmet Korkmaz, Turgut Topal
    J Mol Pathophysiol. 2012; 1(1): 1-2
    » Abstract & References » doi: 10.5455/jmp.20120604123051

  • Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated
    Nicholas P Booth, Wells Brockbank, Samuel Oh, Karl Kingsley
    J Mol Pathophysiol. 2012; 1(1): 29-36
    » Abstract & References » doi: 10.5455/jmp.20120609040915

  • Cytotoxic effects of conjugated linoleic acids on human hepatoma cancer cells (HepG2)
    Achenef Melaku, Arifah Abdul Kadir, Fauziah Othman, Goh Yong Meng, Awis Qurni Sazili
    J Mol Pathophysiol. 2012; 1(1): 43-48
    » Abstract & References » doi: 10.5455/jmp.20120127120302

  • The chemical composition and pharmacological activities of geopropolis produced by Melipona fasciculata Smith in northeast Brazil
    MARIA ARAUJO, MICHELLE BUFALO, BRUNO CONTI, ARY FERNANDES JR., BORYANA TRUSHEVA, VASSYA BANKOVA, JOSE SFORCIN
    J Mol Pathophysiol. 2015; 4(1): 12-20
    » Abstract & References » doi: 10.5455/jmp.20150204115607

  • Modulation of glucose and lipid metabolism in adrenalectomised rats given glycyrrhizic acid
    Yan Qi Ng, Chanchal Chandramouli, So Ha Ton, Khalid Abdul Kadir, Fahreen Haque, Melissa Sharmini Tamotharan
    J Mol Pathophysiol. 2012; 1(1): 3-20
    » Abstract & References » doi: 10.5455/jmp.20120221113254

  • Periodontitis as a risk factor for cardiovascular disease with its treatment modalities: a review
    Amit Bhardwaj, Shalu V. Bhardwaj
    J Mol Pathophysiol. 2012; 1(1): 77-83
    » Abstract & References » doi: 10.5455/jmp.20120206034643

  • Arterial stiffness and inflammation in patients on hemodialysis
    Vaia D. Raikou, Despina Kyriaki, John N. Boletis
    J Mol Pathophysiol. 2012; 1(1): 21-28
    » Abstract & References » doi: 10.5455/jmp.20120530044656

  • Most Cited Articles
  • The chemical composition and pharmacological activities of geopropolis produced by Melipona fasciculata Smith in northeast Brazil
    MARIA ARAUJO, MICHELLE BUFALO, BRUNO CONTI, ARY FERNANDES JR., BORYANA TRUSHEVA, VASSYA BANKOVA, JOSE SFORCIN
    J Mol Pathophysiol. 2015; 4(1): 12-20
    » Abstract & References » doi: 10.5455/jmp.20150204115607
    Cited : 11 times [Click to see citing articles]

  • Importance of HSP70 in Livestock - at cellular level
    SMRUTI RANJAN MISHRA, TAPAN KUMAR PALAI
    J Mol Pathophysiol. 2014; 3(2): 30-32
    » Abstract & References » doi: 10.5455/jmp.20141028023220
    Cited : 8 times [Click to see citing articles]

  • Precision Cut Cancer Tissue Slices in Anti-Cancer Drug Testing
    Florian T Unger, Susanne Bentz, Jana Krüger, Cordula Rosenbrock, Janina Schaller, Katja Pursche, Annika Sprüssel, Hartmut Juhl, Kerstin A David
    J Mol Pathophysiol. 2015; 4(3): 108-121
    » Abstract & References » doi: 10.5455/jmp.20151023055556
    Cited : 7 times [Click to see citing articles]

  • Consumption of a High-Fat Breakfast on Consecutive Days Alters the Area-under-the-curve for Selected CVD Biomarkers
    Brian K McFarlin, Katie C Carpenter, Adam S Venable, Eric A Prado, Andie L Henning
    J Mol Pathophysiol. 2015; 4(1): 6-11
    » Abstract & References » doi: 10.5455/jmp.20150127045909
    Cited : 6 times [Click to see citing articles]

  • Therapeutic potential of metals in managing diabetes mellitus: a review
    Geeta Pandey, Gyan Chand Jain, Nidhi Mathur
    J Mol Pathophysiol. 2012; 1(1): 63-76
    » Abstract & References » doi: 10.5455/jmp.20120410105457
    Cited : 5 times [Click to see citing articles]

  • Prevention and treatment of cyclophosphamide and ifosfamide-induced hemorrhagic cystitis
    Ertan Altaylı, Ercan Malkoc, Bilal Fırat Alp, Ahmet Korkmaz
    J Mol Pathophysiol. 2012; 1(1): 53-62
    » Abstract & References » doi: 10.5455/jmp.20120321060902
    Cited : 5 times [Click to see citing articles]

  • The effect of ethanol extract of Nigerian ficus glumosa leaf on liver function in Diabetic rats
    Umar Zayyanu Usman, Mahaneem Binti Mohamed
    J Mol Pathophysiol. 2015; 4(3): 103-107
    » Abstract & References » doi: 10.5455/jmp.20151022125106
    Cited : 4 times [Click to see citing articles]

  • Proximate and vitamin C analysis of wild edible plants consumed by Bodos of Assam, India
    Hwiyang Narzary1, Ananta Swargiary2 and Sanjay Basumatary3*
    J Mol Pathophysiol. 2015; 4(4): 128-133
    » Abstract & References » doi: 10.5455/jmp.20151111030040
    Cited : 4 times [Click to see citing articles]

  • Disulfiram Neurotoxicity: Decrements in Ethanolamine, Serine, and Inositol Glycerophospholipids.
    Paul L Wood, Ryan S Alexander, Cameron C Felty
    J Mol Pathophysiol. 2014; 3(3): 33-37
    » Abstract & References » doi: 10.5455/jmp.20141122032817
    Cited : 2 times [Click to see citing articles]

  • Inflammatory phenotype of circulating endothelial-derived microparticles in chronic heart failure patients with metabolic syndrome
    Alexander E Berezin, Alexander A Kremzer, Tatyana A Samura, Tatyana A Berezina
    J Mol Pathophysiol. 2015; 4(2): 51-58
    » Abstract & References » doi: 10.5455/jmp.20150402063644
    Cited : 2 times [Click to see citing articles]